AstraZeneca beats by $0.03, beats on revenue

• AstraZeneca (NYSE:AZN): Q4 EPS of $0.94 beats by $0.03.
• Revenue of $6.4B (-4.8% Y/Y) beats by $130M.
• The board declared semi-annual dividend of $1.90/share bringing total annual dividend to $2.80/share. The dividend is payable on March 21 to shareholders of record of Feb. 17.
• FY16 CER guidance: Total Revenue and core EPS to decline in low to mid single-digit percentage including dilutive effects from recent transactions.
• Press Release